Kristin Yarema
Chief Executive Officer presso POSEIDA THERAPEUTICS, INC.
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Kristin Yarema is currently the President, Chief Executive Officer & Director at Poseida Therapeutics, Inc. She is also a Director at the Alliance for Regenerative Medicine and the Celiac Disease Foundation.
Previously, she held the position of Vice President at Amgen, Inc. from 2013 to 2020 and served as the Chief Commercial Officer & Senior Vice President at Atara Biotherapeutics, Inc. from 2020 to 2022.
Dr. Yarema completed her undergraduate degree at Stanford University and obtained a doctorate from the University of California, Berkeley.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 02/01/2024 | 606 836 ( 0.63% ) | 2 M $ | 31/03/2024 |
Posizioni attive di Kristin Yarema
| Società | Posizione | Inizio |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Chief Executive Officer | 01/01/2024 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Director/Board Member | 01/01/2021 |
| Celiac Disease Foundation | Director/Board Member | 01/01/2017 |
Precedenti posizioni note di Kristin Yarema
| Società | Posizione | Fine |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 15/11/2022 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2020 |
Formazione di Kristin Yarema
| Stanford University | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| POSEIDA THERAPEUTICS, INC. | Health Technology |
| ATARA BIOTHERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
| Celiac Disease Foundation |
- Borsa valori
- Insiders
- Kristin Yarema
